|
1
|
Whelan J, McTiernan A, Cooper N, Wong YK,
Francis M, Vernon S and Strauss SJ: Incidence and survival of
malignant bone sarcomas in England 1979–2007. Int J Cancer.
131:E508–E517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Savage SA and Mirabello L: Using
epidemiology and genomics to understand osteosarcoma etiology.
Sarcoma. 2011:5481512011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gill J, Ahluwalia MK, Geller D and Gorlick
R: New targets and approaches in osteosarcoma. Pharmacol Ther.
137:89–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pasquinelli AE, Hunter S and Bracht J:
MicroRNAs: A developing story. Curr Opin Genet Dev. 15:200–205.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou X and Yang PC: MicroRNA: A small
molecule with a big biological impact. Microrna. 1:12012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sassen S, Miska EA and Caldas C: MicroRNA
- implications for cancer. Virchows Arch. 452:1–10. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang L, Shrestha S, LaChaud G, Scott MA
and James AW: Review of microRNA in osteosarcoma and
chondrosarcoma. Med Oncol. 32:6132015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH
and Wang WJ: MicroRNAs in osteosarcoma. Clinica Chimica Acta.
444:9–17. 2015. View Article : Google Scholar
|
|
12
|
Cui R, Guan Y, Sun C, Chen L, Bao Y, Li G,
Qiu B, Meng X, Pang C and Wang Y: A tumor-suppressive microRNA,
miR-504, inhibits cell proliferation and promotes apoptosis by
targeting FOXP1 in human glioma. Cancer Lett. 374:1–11. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao L, Tang M, Hu Z, Yan B, Pi W, Li Z,
Zhang J, Zhang L, Jiang W, Li G, et al: miR-504 mediated
down-regulation of nuclear respiratory factor 1 leads to
radio-resistance in nasopharyngeal carcinoma. Oncotarget.
6:15995–16018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kikkawa N, Kinoshita T, Nohata N, Hanazawa
T, Yamamoto N, Fukumoto I, Chiyomaru T, Enokida H, Nakagawa M,
Okamoto Y, et al: microRNA-504 inhibits cancer cell proliferation
via targeting CDK6 in hypopharyngeal squamous cell carcinoma. Int J
Oncol. 44:2085–2092. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song
JS, Tang LH, Levine AJ and Feng Z: Negative regulation of tumor
suppressor p53 by microRNA miR-504. Mol Cell. 38:689–699. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saadi H, Seillier M and Carrier A: The
stress protein TP53INP1 plays a tumor suppressive role by
regulating metabolic homeostasis. Biochimie. 118:44–50. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tomasini R, Samir AA, Carrier A, Isnardon
D, Cecchinelli B, Soddu S, Malissen B, Dagorn JC, Iovanna JL and
Dusetti NJ: TP53INP1s and homeodomain-interacting protein kinase-2
(HIPK2) are partners in regulating p53 activity. J Biol Chem.
278:37722–37729. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. 1980.
Clin Orthop Relat Res. 415:4–18. 2003. View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Inukai S and Slack F: MicroRNAs and the
genetic network in aging. J Mol Biol. 425:3601–3608. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang MH, Lin BR, Chang CH, Chen ST, Lin
SK, Kuo MY, Jeng YM, Kuo ML and Chang CC: Connective tissue growth
factor modulates oral squamous cell carcinoma invasion by
activating a miR-504/FOXP1 signalling. Oncogene. 31:2401–2411.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Soutto M, Chen Z, Saleh MA, Katsha A, Zhu
S, Zaika A, Belkhiri A and El-Rifai W: TFF1 activates p53 through
down-regulation of miR-504 in gastric cancer. Oncotarget.
5:5663–5673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang B, Gu Y and Chen Y: Identification
of novel predictive markers for the prognosis of pancreatic ductal
adenocarcinoma. Cancer Invest. 32:218–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu J, Li CX, Li YS, Lv JY, Ma Y, Shao TT,
Xu LD, Wang YY, Du L, Zhang YP, et al: MiRNA-miRNA synergistic
network: Construction via co-regulating functional modules and
disease miRNA topological features. Nucleic Acids Res. 39:825–836.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
D'Orazi G, Cecchinelli B, Bruno T, Manni
I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal
G, et al: Homeodomain-interacting protein kinase-2 phosphorylates
p53 at Ser 46 and mediates apoptosis. Nat Cell Biol. 4:11–19. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hofmann TG, Möller A, Sirma H, Zentgraf H,
Taya Y, Dröge W, Will H and Schmitz ML: Regulation of p53 activity
by its interaction with homeodomain-interacting protein kinase-2.
Nat Cell Biol. 4:1–10. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tomasini R, Seux M, Nowak J, Bontemps C,
Carrier A, Dagorn JC, Pébusque MJ, Iovanna JL and Dusetti NJ:
TP53INP1 is a novel p73 target gene that induces cell cycle arrest
and cell death by modulating p73 transcriptional activity.
Oncogene. 24:8093–8104. 2005.PubMed/NCBI
|
|
29
|
Pflaum J, Schlosser S and Müller M: p53
family and cellular stress responses in cancer. Front Oncol.
4:2852014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dötsch V, Bernassola F, Coutandin D, Candi
E and Melino G: p63 and p73, the ancestors of p53. Cold Spring Harb
Perspect Biol. 2:a0048872010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoon MK, Ha JH, Lee MS and Chi SW:
Structure and apoptotic function of p73. BMB Rep. 48:81–90. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Satija YK and Das S: Tyr99 phosphorylation
determines the regulatory milieu of tumor suppressor p73. Oncogene.
35:513–527. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gonzalez S, Prives C and Cordon-Cardo C:
p73alpha regulation by Chk1 in response to DNA damage. Mol Cell
Biol. 23:8161–8171. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ferraris VA, Brown JR, Despotis GJ, Hammon
JW, Reece TB, Saha SP, Song HK, Clough ER, Shore-Lesserson LJ,
Goodnough LT, et al: Society of Thoracic Surgeons Blood
Conservation Guideline Task Force; Society of Cardiovascular
Anesthesiologists Special Task Force on Blood Transfusion;
International Consortium for Evidence Based Perfusion: 2011 update
to the Society of Thoracic Surgeons and the Society of
Cardiovascular Anesthesiologists blood conservation clinical
practice guidelines. Ann Thorac Surg. 91:944–982. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mantovani F, Piazza S, Gostissa M, Strano
S, Zacchi P, Mantovani R, Blandino G and Del Sal G: Pin1 links the
activities of c-Abl and p300 in regulating p73 function. Mol Cell.
14:625–636. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang F, Liu T, He Y, Yan Q, Chen X, Wang
H and Wan X: MiR-125b promotes proliferation and migration of type
II endometrial carcinoma cells through targeting TP53INP1 tumor
suppressor in vitro and in vivo. BMC Cancer. 11:4252011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Q, Han Y, Wang C, Shan S, Wang Y, Zhang
J and Ren T: MicroRNA-125b promotes tumor metastasis through
targeting tumor protein 53-induced nuclear protein 1 in patients
with non-small-cell lung cancer. Cancer Cell Int. 15:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu F, Kong X, Lv L and Gao J: TGF-β1 acts
through miR-155 to down-regulate TP53INP1 in promoting
epithelial-mesenchymal transition and cancer stem cell phenotypes.
Cancer Lett. 359:288–298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ito Y, Motoo Y, Yoshida H, Iovanna JL,
Takamura Y, Miya A, Kuma K and Miyauchi A: Decreased expression of
tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast
carcinoma. Anticancer Res. 26(6B): 1–4395. 2006.PubMed/NCBI
|
|
40
|
Seux M, Peuget S, Montero MP, Siret C,
Rigot V, Clerc P, Gigoux V, Pellegrino E, Pouyet L, N'Guessan P, et
al: TP53INP1 decreases pancreatic cancer cell migration by
regulating SPARC expression. Oncogene. 30:3049–3061. 2011.
View Article : Google Scholar : PubMed/NCBI
|
